Original Research
Published on 13 Mar 2023
The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: A multicenter prospective cohort study
in Vaccines and Molecular Therapeutics
- 2,565 views
- 7 citations